0001209191-19-030638.txt : 20190516
0001209191-19-030638.hdr.sgml : 20190516
20190516193115
ACCESSION NUMBER: 0001209191-19-030638
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190514
FILED AS OF DATE: 20190516
DATE AS OF CHANGE: 20190516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Michael Edward L.
CENTRAL INDEX KEY: 0001391823
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 19833851
MAIL ADDRESS:
STREET 1: 618 SHERIDAN SQUARE
CITY: EVANSTON
STATE: IL
ZIP: 60202
FORMER NAME:
FORMER CONFORMED NAME: Michael Edward L
DATE OF NAME CHANGE: 20070301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-14
0
0000353569
QUIDEL CORP /DE/
QDEL
0001391823
Michael Edward L.
12544 HIGH BLUFF DRIVE
SUITE 200
SAN DIEGO
CA
92130
1
0
0
0
Common Stock
2019-05-15
4
M
0
834
0.00
A
834
D
Restricted Stock Units (Converted)
2019-05-14
4
A
0
1137
0.00
A
Common Stock
1137
1137
D
Restricted Stock Units (Premium)
2019-05-14
4
A
0
341
0.00
A
Common Stock
341
341
D
Restricted Stock Units (Equity Grant)
2019-05-14
4
A
0
2100
0.00
A
Common Stock
2100
2100
D
Reflects release of restricted stock units that were previously reported on Form 4.
Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock.
The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule.
The restricted stock units vest on the date of the grant, May 14, 2019.
The restricted stock units vest on May 14, 2020.
Robert J. Bujarski, attorney-in-fact for Edward L. Michael
2019-05-16